2359 — WuXi AppTec Share Price
Last trade - 00:00- HK$577.63bn
- HK$525.48bn
- CNY45.46bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.99 | ||
| PEG Ratio (f) | 1 | ||
| EPS Growth (f) | 20.36% | ||
| Dividend Yield (f) | 1.68% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.07 | ||
| Price to Tang. Book | 5.2 | ||
| Price to Free Cashflow | 30.83 | ||
| Price to Sales | 8.45 | ||
| EV to EBITDA | 17.91 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 32.51% | ||
| Return on Equity | 31.55% | ||
| Operating Margin | 56.65% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 22,902.39 | 39,354.78 | 40,340.81 | 39,241.43 | 45,456.17 | 61,676.38 | 76,534.56 | 22.42% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +53.64 | +79.68 | +17.54 | -8.87 | +73.32 | +68.57 | +16.13 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
WuXi AppTec Co Ltd is a China-based company principally engaged in the business of new drug research and development and manufacturing services. The Company conducts its business through six segments. The WuXi Chemistry Segment is primarily engaged in providing new drug research, development and manufacturing services. The WuXi Testing Segment is primarily engaged in providing pharmaceuticals, medical devices, and in vitro diagnostic reagents services. The WuXi Biology Segment is primarily engaged in providing drug discovery and research services. The WuXi ATU Segment is primarily engaged in providing customers with integrated medical product process development, manufacturing and testing services. The WuXi DDSU Segment is primarily engaged in providing customers with integrated new drug research and development services. The Other Segment is primarily engaged in administrative services, sales of raw materials and sales of waste materials.
Directors
- Ge Li CHM (59)
- Zhaohui Zhang VPR (56)
- Xiaomeng Tong NED (52)
- Yibing Wu NED (58)
- Qing Yang CCE (57)
- Minzhang Chen CCE (56)
- Ming Shi CFO (51)
- Shaohua Lu-Wong NID (57)
- Wei Yu NID (72)
- Xuesong Leng NID (57)
- Min Han SEC (49)
- Last Annual
- December 31st, 2025
- Last Interim
- September 30th, 2026
- Incorporated
- December 1st, 2000
- Public Since
- May 8th, 2018
- No. of Shareholders
- 297,705
- No. of Employees
- 33,834
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 3,014,755,166
- Address
- 288 Fute Zhong Road, Shanghai, 214092
- Web
- https://www.wuxiapptec.com
- Phone
- +86 2150461000
- Contact
- Min Han
- Auditors
- Deloitte Touche Tohmatsu CPA Ltd.
Latest News for 2359
Similar to 2359
Abbisko Medicine
Stock Exchange of Hong Kong Limited
Akeso
Stock Exchange of Hong Kong Limited
Alphamab Oncology
Stock Exchange of Hong Kong Limited
Antengene
Stock Exchange of Hong Kong Limited
Ascentage Pharma International
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 14:11 UTC, shares in WuXi AppTec are trading at HK$191.60. This share price information is delayed by 15 minutes.
Shares in WuXi AppTec last closed at HK$191.60 and the price had moved by +82.13% over the past 365 days. In terms of relative price strength the WuXi AppTec share price has outperformed the FTSE Developed Asia Pacific Index by +42.98% over the past year.
The overall consensus recommendation for WuXi AppTec is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe WuXi AppTec dividend yield is 1.28% based on the trailing twelve month period.
Last year, WuXi AppTec paid a total dividend of CNY2.09, and it currently has a trailing dividend yield of 1.28%. We do not have any data on when WuXi AppTec is to next pay dividends.
We do not have data on when WuXi AppTec is to next pay dividends. The historic dividend yield on WuXi AppTec shares is currently 1.28%.
To buy shares in WuXi AppTec you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$191.60, shares in WuXi AppTec had a market capitalisation of HK$577.63bn.
Here are the trading details for WuXi AppTec:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2359
Based on an overall assessment of its quality, value and momentum WuXi AppTec is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in WuXi AppTec is HK$238.22. That is 24.33% above the last closing price of HK$191.60.
Analysts covering WuXi AppTec currently have a consensus Earnings Per Share (EPS) forecast of CNY8.41 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like WuXi AppTec. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +64.02%.
As of the last closing price of HK$191.60, shares in WuXi AppTec were trading +24.44% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The WuXi AppTec PE ratio based on its reported earnings over the past 12 months is 16.99. The shares last closed at HK$191.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
WuXi AppTec's management team is headed by:
- Ge Li - CHM
- Zhaohui Zhang - VPR
- Xiaomeng Tong - NED
- Yibing Wu - NED
- Qing Yang - CCE
- Minzhang Chen - CCE
- Ming Shi - CFO
- Shaohua Lu-Wong - NID
- Wei Yu - NID
- Xuesong Leng - NID
- Min Han - SEC